Plus Therapeutics Financial Overview
Plus Therapeutics's market cap is currently $98.95M. The company's EPS TTM is $-0.04; its P/E ratio is ―; Plus Therapeutics is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
